The Effect of Meditation as an Adjuvant Therapy in Chronic Kidney Disease CKD A Pilot Study

Chronic kidney disease (CKD) is a progressive decline in renal function that affects a significant portion of the adult population. It is characterized by structural and functional abnormalities within the kidneys, often remaining asymptomatic during the initial stages but predisposing individuals to various complications, including cardiovascular ailments, end-stage renal failure, anemia, metabolic bone disorders, and neurological manifestations. CKD is typically defined by renal impairment or a glomerular filtration rate (GFR) below 60 mL/min/1.73 m^2, with albuminuria as an additional diagnostic criterion. CKD is associated with coronary artery disease, making managing it complex due to its multifaceted nature and concurrent comorbidities. CKD precipitates premature aging through mechanisms involving increased allostatic load, dysregulated stress response, facilitation of aging processes, and inhibition of anti-aging pathways. CKD patients experience a range of symptoms, including disturbances in sleep patterns, somnolence, fatigue, pruritus, anorexia, muscle cramping, and skeletal pain. Frailty is an independent correlate of heightened symptomatology and compromised health-related quality of life in CKD patients. Depression and anxiety are notably elevated among CKD patients, primarily due to the adverse health outcomes and diminished quality of life associated with the condition. Mind-body therapies, such as meditation, have been investigated for their potential role in CKD patients. Evidence suggests that mindfulness meditation can effectively mitigate chronic pain and mood disturbances, enhancing their overall quality of life. However, further research is needed to explore the potential benefits of meditation and its incorporation into standard treatment regimens for CKD patients undergoing dialysis.

Research on meditation’s impact on chronic kidney disease (CKD) patients has mainly focused on short-term outcomes, highlighting the need for longitudinal studies to evaluate its sustained effects on clinical parameters like dialysis efficacy, renal function, and overall health. The dose-response relationship between meditation practice and therapeutic benefits for CKD patients is unclear, necessitating further investigation to identify the optimal frequency, duration, and type of meditation practice. Evidence suggests meditation can improve emotional resilience and reduce stress in CKD patients, but the exact mechanisms are poorly understood. There is also a need to understand how meditation can be integrated into multidisciplinary healthcare settings, considering feasibility, scalability, and healthcare provider training. This study aims to examine the impact of meditation as an adjunctive therapeutic modality for improving CKD patients’ overall well-being, with potential for integration within the standard care regimen.